Triple-negative breast cancer is different from the more common types of breast cancer. This disease is difficult to treat and much more malignant. Because of its malignancy and rarity, patients with triple-negative breast cancer have few treatment options. The disease also has a higher recurrence rate. According to published figures, this type of cancer accounts for about 10-20% of all breast cancers.

About 10-20% of breast cancers are triple negative breast cancers. Doctors as well as researchers are very interested in finding new drugs to treat triple negative breast cancer. Current studies are trying to understand that some drugs can interfere with the development of triple negative breast cancer.